1. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study. Issue 2 (26th October 2020) Authors: Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun; Tolf, Andreas; Landtblom, Anne-Marie; Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Cherif, Honar; Carlson, Kristina; Lycke, Jan; Burman, Joachim Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 2(2021) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis. Issue 2 (29th November 2016) Authors: Novakova, Lenka; Axelsson, Markus; Khademi, Mohsen; Zetterberg, Henrik; Blennow, Kaj; Malmeström, Clas; Piehl, Fredrik; Olsson, Tomas; Lycke, Jan Journal: Journal of neurochemistry Issue: Volume 141:Issue 2(2017) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis. (January 2017) Authors: Novakova, Lenka; Axelsson, Markus; Khademi, Mohsen; Zetterberg, Henrik; Blennow, Kaj; Malmeström, Clas; Piehl, Fredrik; Olsson, Tomas; Lycke, Jan Journal: Multiple sclerosis Issue: Volume 23:Number 1(2017) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies. (5th March 2019) Authors: Axelsson, Markus; Dubuisson, Nicolas; Novakova, Lenka; Malmeström, Clas; Giovannoni, Gavin; Lycke, Jan; Gnanapavan, Sharmilee Journal: Acta neurologica Scandinavica Issue: Volume 139:Number 5(2019) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study. (May 2022) Authors: Rosenstein, Igal; Axelsson, Markus; Novakova, Lenka; Blennow, Kaj; Zetterberg, Henrik; Lycke, Jan Journal: Multiple sclerosis Issue: Volume 28:Number 6(2022) Page Start: 872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Grid-aware approach to data statistics, data understanding and data preprocessing. (8th June 2009) Authors: Wohrer, Alexander; Novakova, Lenka; Brezany, Peter; Tjoa, A. Min Journal: International journal of high performance computing and networking Issue: Volume 6:Number 1(2009) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation. Issue 3 (15th September 2021) Authors: Rosenstein, Igal; Rasch, Sofia; Axelsson, Markus; Novakova, Lenka; Blennow, Kaj; Zetterberg, Henrik; Lycke, Jan Journal: Journal of neurochemistry Issue: Volume 159:Issue 3(2021) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. (28th November 2017) Authors: Novakova, Lenka; Zetterberg, Henrik; Sundström, Peter; Axelsson, Markus; Khademi, Mohsen; Gunnarsson, Martin; Malmeström, Clas; Svenningsson, Anders; Olsson, Tomas; Piehl, Fredrik; Blennow, Kaj; Lycke, Jan Journal: Neurology Issue: Volume 89:Number 22(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neurofilament light for measuring the treatment efficacy in clinical practice: are we there yet?. Issue 12 (13th October 2019) Authors: Novakova, Lenka Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy. (15th November 2016) Authors: Salzer, Jonatan; Svenningsson, Rasmus; Alping, Peter; Novakova, Lenka; Björck, Anna; Fink, Katharina; Islam-Jakobsson, Protik; Malmeström, Clas; Axelsson, Markus; Vågberg, Mattias; Sundström, Peter; Lycke, Jan; Piehl, Fredrik; Svenningsson, Anders Journal: Neurology Issue: Volume 87:Number 20(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗